Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways.

The Journal of Biological Chemistry
V P SahJ H Brown

Abstract

G protein-coupled receptor agonists initiate a cascade of signaling events in neonatal rat ventricular myocytes that culminates in changes in gene expression and cell growth characteristic of hypertrophy. These responses have been previously shown to be dependent on Gq and Ras. Rho, a member of the Ras superfamily of GTPases, regulates cytoskeletal rearrangement and transcriptional activation of the c-fos serum response element. Immunofluorescence staining of cardiomyocytes shows that Rho is present and predominantly cytosolic. We used two inhibitors of Rho function, dominant negative N19RhoA and Clostridium botulinum C3 transferase, to examine the possible requirement for Rho in alpha1-adrenergic receptor-mediated hypertrophy. Both inhibitors markedly attenuated atrial natriuretic factor (ANF) reporter gene expression induced by alpha1-adrenergic receptor stimulation with phenylephrine, and virtually abolished the increase in ANF reporter gene expression induced by GTPase-deficient Galphaq. These effects were reproduced with the myosin light chain-2 reporter gene. Notably, N19RhoA did not block the ability of activated Ras to induce ANF and myosin light chain-2 reporter gene expression. Furthermore, activation of the extracell...Continue Reading

References

Sep 10, 1992·Nature·J SettlemanR A Weinberg
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H E ShubeitaJ H Brown
Nov 22, 1991·Science·S A Aaronson
Dec 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K R ChienS Chien
Oct 1, 1987·The Journal of Clinical Investigation·N H BishopricC P Ordahl
Oct 20, 1995·The Journal of Biological Chemistry·A M BuhlG L Johnson
Jul 28, 1995·The Journal of Biological Chemistry·K F ToliasC L Carpenter
Aug 25, 1995·The Journal of Biological Chemistry·A M AragayM I Simon
Aug 25, 1995·Cell·A B Vojtek, J A Cooper
Sep 22, 1995·The Journal of Biological Chemistry·V Jullien-FloresJ H Camonis
Jun 2, 1995·The Journal of Biological Chemistry·W H Moolenaar
Aug 18, 1994·Nature·P Rodriguez-VicianaJ Downward
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·N XuJ S Gutkind
Sep 20, 1993·FEBS Letters·H JiangM I Simon
Mar 15, 1996·The Journal of Biological Chemistry·R HooleyD L Barber
Jul 19, 1996·The Journal of Biological Chemistry·L R CollinsJ H Brown

❮ Previous
Next ❯

Citations

Jul 11, 2000·Journal of Molecular and Cellular Cardiology·T UeyamaM Yokoyama
Sep 11, 2001·Journal of Molecular and Cellular Cardiology·P RobertI Berrebi-Bertrand
Apr 2, 2005·Zeitschrift für Kardiologie·M BöhmD J van Veldhuisen
Jun 19, 2010·Journal of Cardiovascular Translational Research·Shigeki MiyamotoJoan Heller Brown
Apr 15, 2004·Journal of Molecular and Cellular Cardiology·Randa Hilal-DandanJoan Heller Brown
Jul 28, 1999·European Journal of Pharmacology·E Nishio, Y Watanabe
Jun 24, 2003·Journal of Molecular and Cellular Cardiology·Hironori NakagamiJames K Liao
Jul 25, 2003·Journal of Molecular and Cellular Cardiology·Hiroshi HasegawaIssei Komuro
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·C Wilde, K Aktories
May 5, 2001·Pharmacology & Therapeutics·G A MichelottiD A Schwinn
Jan 11, 2001·Trends in Cardiovascular Medicine·P H Sugden, A Clerk
Apr 6, 1999·Trends in Cardiovascular Medicine·G W Dorn, J H Brown
Jul 30, 1999·Biochimica Et Biophysica Acta·J H Exton
Dec 3, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Narimasa TakayamaTsutomu Imaizumi
Apr 30, 2005·Seminars in Vascular Medicine·Seema Mital, James K Liao
Oct 21, 1999·The New England Journal of Medicine·J J Hunter, K R Chien
Mar 30, 2001·The Journal of Biological Chemistry·S A SagiJ H Brown
Feb 9, 2010·The Journal of Biological Chemistry·Chantal M MayersJames H Segars
Oct 16, 2008·The Journal of Biological Chemistry·Dominic P Del ReJoan Heller Brown
Jul 9, 2004·Coronary Artery Disease·Hironori Nakagami, James K Liao
Jul 1, 2005·Shock·Jureta W HortonCherry Ballard-Croft
Jun 10, 2011·Journal of Cardiovascular Pharmacology·Erik Ab BuijsDick Tibboel
Nov 3, 2009·Molecular Pharmacology·Mohamed AittalebJohn J G Tesmer
Mar 31, 2005·Molecular and Cellular Biology·Koichiro KuwaharaEric N Olson
Oct 10, 2012·Annual Review of Pharmacology and Toxicology·John D ScottKjetil Taskén
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R L NicolE N Olson
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·V P SahJ H Brown
Jan 14, 2003·Annual Review of Physiology·N Frey, E N Olson
Mar 16, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Masahiko Hoshijima
Jul 13, 2011·The Journal of Clinical Investigation·Sunny Yang XiangJoan Heller Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.